You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Moodys
McKesson
Boehringer Ingelheim
Dow

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

FLUOXETINE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Fluoxetine patents expire, and when can generic versions of Fluoxetine launch?

Fluoxetine is a drug marketed by Sun Pharm Industries, Watson Labs, Barr, Dr Reddys Labs Ltd, Alembic Pharms Ltd, Ani Pharms Inc, Apnar Pharma Lp, Aurobindo Pharma, Beximco Pharms Usa, Cadila Pharms Ltd, Carlsbad, Celltrion, Cr Double Crane, Heritage Pharms Inc, Ivax Sub Teva Pharms, Landela Pharm, Marksans Pharma, Mylan, Mylan Pharms Inc, Par Pharm, Sandoz, Sciegen Pharms Inc, Specgx Llc, Sun Pharm Inds Ltd, Teva, Teva Pharms Usa, Actavis Mid Atlantic, Aurobindo Pharma Ltd, Hi Tech Pharma, Lannett Co Inc, Nostrum Labs Inc, Pharm Assoc, Wockhardt Bio Ag, Alvogen, Fosun Pharma, G And W Labs Inc, Inventia Hlthcare, Lupin Ltd, Par Form, Par Pharm Inc, Taro, Torrent, and Upsher Smith Labs. and is included in sixty-two NDAs.

The generic ingredient in FLUOXETINE is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-one suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.

Drug patent expirations by year for FLUOXETINE
Drug Prices for FLUOXETINE

See drug prices for FLUOXETINE

Drug Sales Revenue Trends for FLUOXETINE

See drug sales revenues for FLUOXETINE

Recent Clinical Trials for FLUOXETINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Toledo Health Science CampusPhase 4
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineN/A
Huadong HospitalN/A

See all FLUOXETINE clinical trials

US Patents and Regulatory Information for FLUOXETINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nostrum Labs Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride SOLUTION;ORAL 075292-001 Feb 7, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Sciegen Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 210935-002 Mar 20, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Marksans Pharma FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075465-001 Jan 29, 2002 AB1 RX No No   Start Trial   Start Trial   Start Trial
Cr Double Crane FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 076165-002 Feb 1, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 211721-001 Jan 25, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan Pharms Inc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075577-001 Jan 29, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
Specgx Llc FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride CAPSULE;ORAL 075658-002 Jan 29, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Mallinckrodt
Merck
Baxter
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.